Business Standard

Markets extend gains led by drugmakers, banks

Cipla, Sun Pahrma, ICICI Bank rises

Read more on:    Nifty | Sensex | Noon | Winter Session | Us Fiscal Cliff
Related News

Indian shares extended gains in late morning trades amid hopes that the Congress-led UPA government may muster a majority to pass key reforms in the of Parliament starting November 22.

Buying was witnessed in pharmaceutical companies such as Cipla, Sun Pharma and software majors Inofsys and TCS while private banks such as HDFC Bank and ICICI Bank also supported on the upside.

At 11:25AM, the Bombay Stock Exchange's index was up 104 points to 18,433.39 while the National Stock Exchange's index gained 27 points to 5,598.10 levels.

Global risk appetite was slightly weak as investors squared positions before the Thanksgiving holiday on Thursday and a long weekend.

Meanwhile, US markets slipped back into negative territory on Tuesday after Federal Reserve Chairman Ben Bernanke signalled at significant downside risk to the world's biggest economy if government fails to strike a deal to prevent a fiscal shortfall of some $600 billion.

Asian markets traded mixed. Hang Seng was up 60 points at 21,288, Nikkei advanced 40 points to 9,183, Seoul Composite fell 9points to 1,881 and the Taiwan Weighted was down 69 points at 7,076.

Back home, markets traded firm on hopes the government may get support from Tamil Nadu’s DMK and the Uttar Pradesh-based parties, SP and BSP, will to push forward earlier nnounced reforms.

“The impact of political risks on the market over the next month or so is a bit exaggerated," said Suresh Mahadeven, managing director-head of India equities at investment bank UBS. “It looks like the government is on a stable footing as of now."

On the sectoral front, real-estate, banks, fast moving consumer goods on BSE rose between 1-1.3% each while auto and power companies were among the laggards, falling between 0.03-0.2% in the late morning trades.

Among the losers, BHEL fell 1% while Maruti Suzuki and Hero MotoCorp dropped 1% each.

Aided by a weak rupee, sales from niche opportunities, product launches and strong base business Indian pharmaceutical majors reported a 30% revenue growth for the quarter ended September 2012. Cipla, Sun Pharmaceuticals rose over 1% each. 

Major software exporters firmed up on the back of a weakening rupee. Infosys and TCS were up nearly 0.9% each.

ICICI Bank and HUL gained 2% and 1% respectively on the BSE.

Among other notable movers, Mphasis has dipped 3% to Rs 388 on reports that Hewlett-Packard Co (HP) said it took an $8.8 billion charge related to its acquisition of software firm Autonomy, citing "serious accounting improprieties," as it swung to a fourth-quarter loss

DB Realty has rallied 6% to Rs 121 on back of heavy volumes on reports that the Bharti Group is planning to buy a majority stake in the company’s hospitality arm DB Hospitality for Rs 350 crore.

SpiceJet is trading higher by over 3% at Rs 35.95 on reports of stake sale of the company after the resignation of Kalanithi Maran and his wife Kavery Kalanithi from the board of directors of Kal Airways.

The BSE mid-cap and small-cap indices also rose nearly 0.3% each.

The overall breadth is positive as 1,276 stocks have advanced while 984 stocks declined.

Read more on:   
|
|
|
|

Read More

BSE launches carbon index

Premier bourse BSE, in collaboration with the UK government, today launched BSE Carbonex, the first-of-its-kind index in India or any emerging market ...

Quick Links

 

Market News

FIIs stake in ICICI Bank hit 6-year high

FIIs increased their stake in ICICI Bank to 39.85% in March 2014 quarter from 38.39% at the quarter ended December 2013.

Chilli teja surges 3.25% on strong demand

Traders create fresh positions as tight supplies from grwoing areas add to positive sentiment

Mindtree gains on 1:1 bonus issue, strong Q4 earnings

The board has recommended a total dividend of 150% or Rs 15 per equity share of par value Rs 10 each, include a special dividend of 50% for ...

Oil prices rise in Asian trade

However, a bearish US stockpiles report was dampening sentiment

Pre-market: TCS, HCL Tech in focus on robust Q4 earnings

Markets are likely to rebound on buying in TCS and HCL Tech post robust Q4 earnings

Back to Top